Literature DB >> 26897387

Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases.

Franco Rongioletti1, Giulia Merlo2, Carla Carli3, Bernard Cribier4, Dieter Metze5, Eduardo Calonje6, Werner Kempf7, Catherine M Stefanato6, Eduardo Marinho8, Jean Kanitakis9.   

Abstract

BACKGROUND: Few histologic studies describe the histopathologic aspects of scleromyxedema.
OBJECTIVE: We sought to describe the histopathologic and immunohistochemical features of scleromyxedema in a large series of patients.
METHODS: We studied all the cases with scleromyxedema diagnosed between 2000 and 2014 at participating centers. Sections with hematoxylin-eosin and special stains were examined. Immunohistochemistry for CD3, CD4, CD8, CD20, CD68, and factor XIIIa was performed in 10 cases.
RESULTS: A total of 44 skin biopsy specimens from 34 patients were reviewed. Two different histopathologic patterns were observed: the classic microscopic triad (dermal mucin deposition, fibroblast proliferation, fibrosis) was identified in 34 specimens, whereas an interstitial granuloma annulare-like pattern was found in 10 specimens. A superficial perivascular infiltrate with T lymphocytes was found in all specimens whereas an interstitial proliferation of CD68(+) epithelioid cells was identified in the 10 specimens with an interstitial granuloma annulare-like pattern. Elastic fibers were largely lost, explaining the redundant folds of the disease. LIMITATIONS: This was a retrospective study.
CONCLUSIONS: Scleromyxedema shows 2 histopathologic patterns, including the classic type with the microscopic triad of mucin, fibroblast proliferation and fibrosis, and an interstitial granuloma annulare-like pattern. Recognition of these histologic presentations expands the spectrum of scleromyxedema and highlights the difficulty in diagnosing this disabling condition in the absence of a clinicopathological correlation.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fibromucinous disorder; histopathology; immunohistochemistry; interstitial granulomatous dermatitis; lichen myxedematosus; scleromyxedema

Mesh:

Substances:

Year:  2016        PMID: 26897387     DOI: 10.1016/j.jaad.2015.12.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  [Granulomatous reaction pattern of the skin : Interstitial granulomatous dermatitis - lymphoma - vasculitis].

Authors:  C Rose; K Holl-Ulrich
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

3.  Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin.

Authors:  Christopher A Mecoli; C Conover Talbot; Andrea Fava; Christopher Cheadle; Francesco Boin; Fredrick M Wigley; Laura K Hummers
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05-14       Impact factor: 4.794

Review 4.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

5.  Generalized Nodules and Sclerosis of the Skin: A Quiz.

Authors:  Miriam Mengoni; Andreas Dominik Braun; Evelyn Gaffal
Journal:  Acta Derm Venereol       Date:  2021-09-22       Impact factor: 3.875

6.  Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.

Authors:  Abtin Ansari; Zohre Erfani; Maryam Daneshpazhooh; Leila Mahmoudi; Zahra Saffarian; Kambiz Kamyab; Hamidreza Mahmoudi
Journal:  Case Rep Dermatol       Date:  2022-06-27

7.  Monoclonal gammopathies of clinical significance.

Authors:  Angela Dispenzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 8.  Diagnosis and management of monoclonal gammopathy of clinical significance.

Authors:  Hyungwoo Cho
Journal:  Blood Res       Date:  2022-04-30

9.  Improvement of plaquelike cutaneous mucinosis after intravenous immunoglobulins treatment.

Authors:  Jorge Magdaleno-Tapial; Cristian Valenzuela-Oñate; Álvaro Martínez-Doménech; Marta García-Legaz-Martínez; Juan José Tamarit-García; Violeta Zaragoza-Ninet; Víctor Alegre-de Miquel; Amparo Pérez-Ferriols
Journal:  JAAD Case Rep       Date:  2020-06-15

10.  An unusual presentation of scleromyxedema as inflammatory myopathy.

Authors:  Kavadisseril Vivekanandan Vysakha; Rajalakshmi Poyuran; Sruthi S Nair; Muralidharan Nair
Journal:  Acta Myol       Date:  2019-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.